J1805 HCPCS code: Injection, esmolol hydrochloride, 10 mg
J1805 is the HCPCS Level II code for injection, esmolol hydrochloride, 10 mg. In 2024 Medicare paid an average of $0.18 per service for J1805 across 413 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 694% from 2023 to 2024 (52 to 413 services). In 2024, about 25 clinicians billed Medicare for J1805 for 108 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J1805 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 25 |
| Medicare beneficiaries | 108 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1805, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 52 | 20 | $0.24 | $0.19 |
| 2024 | 413 | 108 | $0.23 | $0.18 |
States with the most J1805 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| North Carolina | 120 | $0.18 |
| Mississippi | 115 | $0.19 |
| Louisiana | 51 | $0.16 |
| New York | 14 | $0.20 |
What changed for J1805
- 2023-07-01: J1805 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1805?
J1805 is the HCPCS Level II code for injection, esmolol hydrochloride, 10 mg. Short descriptor: "Inj, esmolol hcl, 10mg".
How much does Medicare pay for J1805?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.23).
Does Medicare cover J1805?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J18 codes
- J1800 — Injection, propranolol hcl, up to 1 mg
- J1806 — Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807 — Injection, ethacrynate sodium, 1 mg
- J1808 — Injection, folic acid, 0.1 mg
- J1809 — Injection, fosdenopterin, 0.1 mg
- J1810 — Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- J1811 — Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812 — Insulin (fiasp), per 5 units
- J1813 — Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814 — Insulin (lyumjev), per 5 units
- J1815 — Injection, insulin, per 5 units
- J1817 — Insulin for administration through dme (i.e., insulin pump) per 50 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1805
- Watch J1805 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1805
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.